MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A

Daozhang Yuan1, Shunsheng Zheng1, Liyan Wang1

  • 1Department of Urology, Cancer Center of Guangzhou Medical University, Guangzhou, People's Republic of China.

Oncotarget
|October 6, 2017
PubMed